AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in cancer treatment
Published on: Feb. 10, 2026, 3:37 p.m. | Source: Lokmat Times
AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in cancer treatment - New Delhi, Feb 10 AstraZeneca Pharma India Limited on Tuesday said it has received permission from the Central ... Get Latest News on Business only on lokmattimes.com
